Novavax, Inc. is a NASDAQ-listed company with a current market cap of 86.62 billion dollars as of 2nd February 2023. The company’s stock price has seen an increase of 2.61 percent since the previous close on 1st February and is currently trading at 10.19 USD per share. The day high was recorded at 10.28 USD while its day low was 9.78 USD on the same date.
Since it attained its year high of 91 USD on 3rd November 2021, the company has witnessed a significant drop in market capitalisation to 866 million USD on 1st February 2023 from 954 million USD on 3rd February 2023 and 1.02 billion USD on 2nd February 2023 respectively; however, it has recovered slightly since then, with the closing price averaging 12.02 USD for the past 50 days and 31.74 USD over 200 days respectively.
Novavax’s earnings per share (EPS) stands at -17.509 while its price to earnings ratio (P/E) remains undefined due to negative EPS value; further, the company’s shares outstanding are currently rated at 85 million as of publication date and trading volumes over the past 24 hours have been recorded at 3 million shares with average daily volume standing at 6 million shares for reference purposes
